Evidence map›Paper›PMID 38276038›Full record

ArticleMedicina (Kaunas, Lithuania)2023

Role of Novel Inflammatory Factors in Central Retinal Vein Occlusion with Macular Edema.

Kanako Yasuda, Hidetaka Noma, Tatsuya Mimura, Ryota Nonaka, Shotaro Sasaki, Akemi Ofusa, Masahiko Shimura

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kanako YasudaDepartment of Ophthalmology, Hachioji Medical Center, Tokyo Medical University, 1163, Tatemachi, Hachioji 193-0998, Japan.
Hidetaka NomaDepartment of Ophthalmology, Hachioji Medical Center, Tokyo Medical University, 1163, Tatemachi, Hachioji 193-0998, Japan.ORCID 0000-0001-6925-3063
Tatsuya MimuraDepartment of Ophthalmology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8606, Japan.
Ryota NonakaDepartment of Ophthalmology, Hachioji Medical Center, Tokyo Medical University, 1163, Tatemachi, Hachioji 193-0998, Japan.
Shotaro SasakiDepartment of Ophthalmology, Hachioji Medical Center, Tokyo Medical University, 1163, Tatemachi, Hachioji 193-0998, Japan.
Akemi OfusaDepartment of Ophthalmology, Hachioji Medical Center, Tokyo Medical University, 1163, Tatemachi, Hachioji 193-0998, Japan.
Masahiko ShimuraDepartment of Ophthalmology, Hachioji Medical Center, Tokyo Medical University, 1163, Tatemachi, Hachioji 193-0998, Japan.
Tokyo Medical University Hachioji Medical Center · JPTeikyo University · JP

Funding

Hidetaka Noma 22K09821
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Macular EdemaRetinal Vein OcclusionHumansPrognosisRanibizumabTomography, Optical CoherenceVascular Endothelial Growth Factor ARanibizumabVascular Endothelial Growth Factor Aanti-VEGF therapycentral retinal vein occlusionCXCL-16endocan-1FMS-related tyrosine kinase 3 ligandmacular edema

Identifiers

PMID38276038
PMCPMC10817650
OpenAlexW4389935266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.